Delivery Order SPE2DB24D2018-SPE2DB25FWVD4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,461.79 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed price contract type. This non-competitive delivery order was issued on June 16, 2025, with an ultimate completion date of June 17, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,044.44 on July 25, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) under a competitive, non-set-aside procurement. The order carries a firm fixed price and is scheduled for ultimate completion by July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,304.62 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. The place...
- The Defense Logistics Agency awarded a delivery order valued at $37,329.50 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on September 4, 2025, with completion targeted for September 5, 2025. This non-competed, firm fixed-price delivery order is issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a $7,835.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on May 30, 2025, with an ultimate completion date of June 2, 2025. The award was competitively procured with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 29, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply NURTEC ODT 75 mg tablets (8-count units) under a firm fixed-price contract valued at $9,259.00. The order is scheduled for completion by September 2, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and represents a child contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,177.74 on August 29, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 2, 2025, with performance executed from the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) valued at $14,433.09. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The order will be fulfilled from the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $45,921.16 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 MG tablets (8-count units) with a firm fixed price and September 22, 2025 completion date. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical vendor supporting federal medical procurement needs. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $23,382.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on September 15, 2025, with completion scheduled for September 16, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was fulfilled...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB25FWVD4Delivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $17,511.43 by the Defense Logistics Agency (DLA) to supply NURTEC ODT 75 mg tablets in quantities of 8 units. The contract, awarded on June 18, 2025, utilizes firm fixed pricing with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside order. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated extensive capability in fulfilling DLA medical supply requirements through numerous competitively awarded contracts covering diverse therapeutic domains. The company serves multiple federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard, through its flexible contract vehicles. NURTEC ODT is a migraine treatment medication, reflecting the company's broader portfolio of neurological and specialty pharmaceutical products supplied to military and veteran healthcare systems. As the DLA Troop Support plans to establish new Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, AmerisourceBergen's existing performance demonstrates its qualifications for continued engagement in military pharmaceutical supply operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.5k | 6/18/25 |